Ray Dalio Omnicell, Inc Transaction History
Bridgewater Associates, LP
- $17.3 Billion
- Q3 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Omnicell, Inc stock. As of the latest transaction made, Bridgewater Associates, LP holds 17,929 shares of OMCL stock, worth $807,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,929
Previous 38,286
53.17%
Holding current value
$807,880
Previous $1.04 Million
24.61%
% of portfolio
0.0%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding OMCL
# of Institutions
277Shares Held
44.6MCall Options Held
224KPut Options Held
35.7K-
Black Rock Inc. New York, NY8.18MShares$369 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.53MShares$249 Million0.0% of portfolio
-
State Street Corp Boston, MA2.27MShares$102 Million0.0% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.55MShares$69.7 Million0.43% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.25MShares$56.2 Million0.01% of portfolio
About OMNICELL, Inc
- Ticker OMCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 44,288,800
- Market Cap $2B
- Description
- Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...